Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 12, 2026

Mar. 12, 2026

CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

GlobeNewswire

Mar. 12, 2026

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 12, 2026

iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching

GlobeNewswire

Mar. 12, 2026

Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 12, 2026

Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 12, 2026

Health Catalyst Reports Fourth Quarter and Year End 2025 Results

GlobeNewswire

Mar. 12, 2026

The Joint Corp. Reports 2025 Fourth Quarter and Full Year Financial Results

GlobeNewswire

Mar. 12, 2026

Picard Medical / SynCardia to Host Annual Business Update Featuring Key Opinion Leaders and Patient Testimonial

GlobeNewswire

Mar. 12, 2026

Vaxart Provides Business Update and Reports Full Year 2025 Financial Results

GlobeNewswire

Mar. 12, 2026

Allogene Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update

GlobeNewswire

Mar. 12, 2026

BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results

GlobeNewswire

Mar. 12, 2026

Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results

GlobeNewswire

Mar. 12, 2026

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 12, 2026

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026

GlobeNewswire

Mar. 12, 2026

Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 12, 2026

Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Mar. 12, 2026

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

Mar. 12, 2026

Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement

GlobeNewswire

Mar. 12, 2026

Koelis stellt auf der EAU 2026 innovative Produkte vor, die die Arbeitsabläufe bei der MRT-Fusionsbiopsie verbessern und die fokale Therapie bei Prostatakrebs fördern

GlobeNewswire

Mar. 12, 2026

Koelis annonce, à l’occasion du Congrès de l’EAU 2026, des innovations technologiques destinées à optimiser les flux de travail de biopsie par fusion IRM et à soutenir le développement de la thérapie focale dans la prise en charge du cancer de la prost…

GlobeNewswire